Muktar Sano Kedir

ORCID: 0000-0003-2365-6523
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Global Maternal and Child Health
  • HIV/AIDS drug development and treatment
  • Natural Compounds in Disease Treatment
  • Diverse Scientific Research Studies
  • HIV/AIDS Research and Interventions
  • HIV Research and Treatment
  • Child Nutrition and Water Access
  • Global Public Health Policies and Epidemiology
  • Trauma and Emergency Care Studies
  • Pneumonia and Respiratory Infections
  • Saffron Plant Research Studies
  • Tuberculosis Research and Epidemiology
  • Urban Transport and Accessibility
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Colorectal Cancer Screening and Detection
  • Chronic Disease Management Strategies
  • Ocular Diseases and Behçet’s Syndrome
  • Diabetes Management and Research
  • Malaria Research and Control
  • Global Cancer Incidence and Screening
  • Synthesis and bioactivity of alkaloids
  • Health disparities and outcomes
  • Emergency and Acute Care Studies
  • Neurological Disease Mechanisms and Treatments
  • Healthcare Systems and Public Health

Arsi University
2021-2024

Asossa University
2021

Mizan Tepi University
2015-2019

BackgroundThe Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2015 provides an up-to-date analysis the burden lower respiratory tract infections (LRIs) in 195 countries. This study assesses cases, deaths, aetiologies spanning past 25 years shows how LRI has changed people all ages.MethodsWe estimated mortality by age, sex, geography, year using a modelling platform shared across most causes death GBD called Cause Death Ensemble model. We modelled morbidity, including...

10.1016/s1473-3099(17)30396-1 article EN cc-by The Lancet Infectious Diseases 2017-08-23
Hmwe Hmwe Kyu Emilie R Maddison Nathaniel J Henry John Everett Mumford Ryan M Barber and 95 more Chloe Shields Jonathan C. Brown Grant Nguyen Austin Carter Timothy M Wolock Haidong Wang Patrick Y Liu Marissa B Reitsma Jennifer M. Ross Amanuel Alemu Abajobir Kalkidan Hassen Abate Kaja Abbas Mubarek Abera Semaw Ferede Abera Habtamu Abera Hareri Muktar Beshir Ahmed Kefyalew Addis Alene Nelson Alvis‐Guzmán Joshua Amo‐Adjei Jason R. Andrews Hossein Ansari Carl Abelardo T. Antonio Palwasha Anwari Hamid Asayesh Tesfay Mehari Atey Sachin Atre Aleksandra Barać Justin Beardsley Neeraj Bedi Isabela M. Benseñor Addisu Shunu Beyene Zahid A Butt Pere‐Joan Cardona Devasahayam Jesudas Christopher Lalit Dandona Rakhi Dandona Kebede Deribe Amare Deribew Rebecca Ehrenkranz Maysaa El Sayed Zaki Aman Yesuf Endries Tesfaye Regassa Feyissa Florian Fischer Ruoyan Gai Alberto L. García‐Basteiro Tsegaye Tewelde Gebrehiwot Hailay Abrha Gesesew Belete Getahun Philimon Gona Amador Goodridge H. C. Gugnani Hassan Haghparast‐Bidgoli Gessessew Bugssa Hailu Hamid Yimam Hassen Esayas Haregot Hilawe Nobuyuki Horita Kathryn H. Jacobsen Jost B Jonas Amir Kasaeian Muktar Sano Kedir Laura Kemmer Yousef Khader Ejaz Ahmad Khan Young‐Ho Khang Abdullah T Khoja Yun Jin Kim Parvaiz A Koul Ai Koyanagi Kristopher J Krohn G Anil Kumar Michael Kutz Rakesh Lodha Hassan Magdy Abd El Razek Reza Majdzadeh Tsegahun Manyazewal Ziad A. Memish Walter Mendoza Haftay Berhane Mezgebe Shafiu Mohammed Felix Akpojene Ogbo In‐Hwan Oh Eyal Oren Aaron Osgood‐Zimmerman David M. Pereira Dietrich Plaß Farshad Pourmalek Mostafa Qorbani Anwar Rafay Mahfuzar Rahman Rajesh Kumar Puja C Rao Sarah E Ray Robert C. Reiner Nickolas Reinig Saeid Safiri

An understanding of the trends in tuberculosis incidence, prevalence, and mortality is crucial to tracking success control programmes identification remaining challenges. We assessed fatal non-fatal burden over past 25 years for 195 countries territories.

10.1016/s1473-3099(17)30703-x article EN cc-by The Lancet Infectious Diseases 2017-12-07

BackgroundThe incidence of resistance among currently available antimalarial drugs, as well the high economic cost malaria, has prompted researchers to look for novel molecules. As a result, current study was proposed evaluate antiplasmodial activity (in vivo) Maytenus gracilipes based on plant's traditional claims.MethodsA cold maceration procedure using 80% methanol solvent employed obtain crude extract from M. leaves. Chloroform, n-butanol, and pure water were used fractionate...

10.1016/j.heliyon.2021.e08457 article EN cc-by-nc-nd Heliyon 2021-11-01

The evolution of resistance to currently used malaria medicines together with the severe economic burden initiates search for novel antimalarial drugs. Thus, present experiment was intended assess in vivo antiplasmodial effect Gardenia ternifolia based on traditional claims and vitro plant.For crude extraction stem barks G. ternifolia, a cold maceration method using hydromethanol as solvent employed. hydroalcoholic extract then fractionated by three solvents (chloroform, n-butanol, aqueous...

10.1155/2021/9625169 article EN Evidence-based Complementary and Alternative Medicine 2021-09-01

Abstract Purpose Liver disease is a growing public health problem both in developing and developed countries. Allopathic medicines available for liver are not accessible affordable 3 rd world countries, like Ethiopia. There need to search alternative therapy, which herbals widely used traditional medicine promising the development of effective less costly treatment. As result, this study aimed screen phytochemicals investigate toxic hepatoprotective effects Prunus africana traditionally...

10.1101/2024.04.11.588968 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2024-04-18

One of the most difficult challenges in carrying out global health research developing world is issue copyright protection questionnaires. The current reality that often hampered by inadequate or even non-existent budgetary support. From our point view, an additional hindrance to countries insistence holders questionnaire copyrights they are paid for use their testing instruments. adverse consequence demands compensation may be worthwhile impeded prevented. It argued practice charging...

10.3389/fpubh.2019.00377 article EN cc-by Frontiers in Public Health 2019-12-18
Coming Soon ...